CoChat

Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications

Kang-Mieler, Jennifer J., Dosmar, Emily, Liu, Wenqiang, Mieler, William F. · 2017 · Expert Opinion on Drug Delivery

The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: The development of new therapies for treating various eye conditions has led to a demand for extended release delivery systems, which would lessen the need for frequent application while still achieving therapeutic drug levels in the target tissues. Areas covered: Following an overview of the different ocular drug delivery modalities, this article surveys the biomaterials used to develop sustained release drug delivery systems. Microspheres, nanospheres, liposomes, hydrogels, and composite systems are discussed in terms of their primary materials. The advantages and disadvantages of each drug delivery system are discussed for various applications. Recommendations for modifications and strategies for improvements to these basic systems are also discussed. Expert opinion: An ideal sustained release drug delivery system should be able to encapsulate and deliver the necessary drug to the target tissues at a therapeutic level without any detriment to the drug. Drug encapsulation should be as high as possible to minimize loss and unless it is specifically desired, the initial burst of drug release should be kept to a minimum. By modifying various biomaterials, it is possible to achieve sustained drug delivery to both the anterior and posterior segments of the eye.

Overview

Integrity signals

Registry

Crossref · 10.1080/17425247.2016.1227785

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 103 references

Research works printed but not linked: 9

  1. Ahmed I, 1985, Invest Ophthalmol Vis Sci, 26, 584
  2. Natarajan JV, 2012, Int J Nanomedicine, 7, 123
  3. Bressler NM, 2001, Arch Ophthalmol, 119, 198
  4. Kang-Mieler JJ, 2011, Duane’s Ophthalmol
  5. Hu C-C, 2014, Biomed Mater Eng, 24, 1941
  6. Drapala PW, 2010, J Biomat Sci Polym Edn
  7. Kang Derwent JJ, 2008, Trans Am Ophthalmol Soc, 106
  8. Moritera T, 1991, Invest Ophthalmol Vis Sci, 32, 1785
  9. Hughes PM, 2011, Intraocular pressure reduction with intracameral bimatoprost implants

Cited by

See all 76

Metadata

Authors
Kang-Mieler, J. J., Dosmar, E., Liu, W., & Mieler, W. F.
Affiliations
  • Illinois Institute of Technology (US)
  • University of Illinois Chicago (US)
Venue
Expert Opinion on Drug Delivery
Published
2016-09
Volume
14
Issue
5
Pages
611-620
ISSN
  • 1742-5247 (ISSN-L)
  • 1744-7593
OpenAlex
W2513574704
Cited by
73
References
102
Citations by year
2026: 6 · 2025: 4 · 2024: 11 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 16 · 2019: 6 · 2018: 6 · 2017: 5 · 2016: 1
FWCI
0.51
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Drug Delivery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Ophthalmology › Ocular Surface and Contact Lens
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
ocular drug delivery, sustained drug release, biomaterials, microspheres, nanospheres, liposomes, hydrogels, anterior segment, posterior segment, burst release, drug encapsulation, ocular implants
MeSH terms
Biocompatible Materials, Delayed-Action Preparations, Eye, Eye Diseases, Humans, Liposomes, Microspheres, Drug Delivery Systems, Hydrogels, Drug Liberation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications. https://app.cochat.ai/papers/10.1080/17425247.2016.1227785
The paper
Kang-Mieler, J. J., Dosmar, E., Liu, W., & Mieler, W. F. (2017). Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications. Expert Opinion on Drug Delivery. https://doi.org/10.1080/17425247.2016.1227785

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.